Screening and Risk Reduction for Dementia in Primary Care

    Project: Research

    Project Details

    Description

    Risk reduction for cognitive decline and dementia is a national priority. Without a cure for dementia, and an ageing population, risk reduction is an important step to reduce the societal and economic costs associated with dementia. Modifiable risk factors have been identified and estimates suggest that reduction of these risks could lead to dramatic decreases in the prevalence of dementia. This project aims to evaluate the effectiveness and cost-effectiveness of an online tool implemented in primary care to reduce risk for dementia compared to treatment as usual in a randomised controlled trial. The systematic semi-automated GP online tool will be integrated with primary care software, use clinical cut-offs on standardised measures and clinical management guidelines to generate a dementia risk matrix to calculate personalised risk profiles for adults aged 60 to 70 years of age. Integrating consumer feedback during this project design, patients will: 1) be educated about their risk using a patient-centered personalised medicine approach, 2) design a mitigation plan collaboratively with their GP and 3) choose their preferred evidence-based interventions and services in their local community including online, self-help, telephone based and face-to-face. The tool will be trialled in the Sydney North Primary Health Network utilising its GPs, practice nurses and psychologists. Progress will be reviewed using the tool at 3, 6, and 12 months post baseline compared to treatment as usual. Additional projects will be run alongside the clinical trial to further increase knowledge and research capacity such as seeking consumer and GP feedback to improve the tool, examining moderators of treatment success, and changes in cognitive measures sensitive to early decline. This novel project will help to better identify individuals at risk and engage patients in preventative medicine approaches that offer the potential to result in wide scale risk reduction for cognitive decline.
    StatusActive
    Effective start/end date1/01/2131/12/25